ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $97,000 | -50.3% | 42,259 | -5.0% | 0.04% | -46.2% |
| Q2 2021 | $195,000 | -59.3% | 44,471 | -32.6% | 0.08% | -60.4% |
| Q1 2021 | $479,000 | +71.1% | 66,007 | +1.8% | 0.20% | +74.1% |
| Q4 2020 | $280,000 | +68.7% | 64,838 | +60.9% | 0.12% | +33.3% |
| Q3 2020 | $166,000 | -39.6% | 40,292 | -12.0% | 0.09% | -33.1% |
| Q2 2020 | $275,000 | +25.6% | 45,787 | +57.3% | 0.13% | +44.4% |
| Q1 2020 | $219,000 | -52.3% | 29,107 | -12.8% | 0.09% | +20.0% |
| Q4 2019 | $459,000 | +122.8% | 33,365 | +92.1% | 0.08% | +78.6% |
| Q3 2019 | $206,000 | -19.5% | 17,366 | -5.3% | 0.04% | -22.2% |
| Q2 2019 | $256,000 | – | 18,333 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |